Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$41.50
0.621.52%
Last update: Dec 15, 8:42 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Who are Exelixis (EXEL) competitors?
Other companies in Exelixis’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).
What is the forecast, or price target, for Exelixis (EXEL) stock?
Exelixis has a consensus price target of $44.21.
What is the current price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $41.5 last updated December 15, 2025 at 8:42 AM EST.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis does not have any upcoming earnings scheduled.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
